Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ammonia absorption in the colon refers to the movement of ammonia from the lumen of the colon across the epithelial barrier into the systemic circulation[5][3]. This process depends on the form of ammonia present; nonionic NH₃ can diffuse passively, while NH₄⁺ (ammonium ion) is less readily absorbed[5][3][4]. Colonic acidification, such as that induced by lactulose therapy, promotes formation of NH₄⁺, limiting ammonia absorption and lowering plasma ammonia—an effect exploited therapeutically to reduce complications of liver disease, notably hepatic encephalopathy[1][4]. This entity is best categorized as a physiological process with important pathophysiological and therapeutic implications, rather than a molecular target. Thus, it does not conform to the typical structure of druggable targets such as receptors, enzymes, or transporters.
Lactulose acidifies the colonic contents, trapping ammonia as non-absorbable ammonium ion (NH₄⁺), thereby reducing ammonia absorption[1][4]. Rifaximin alters colonic microbiota, decreasing ammoniagenesis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ammonia absorption in colon.